Identification of Asp95 as the site of succinimide formation in recombinant human glial cell line-derived neurotrophic factor

被引:8
作者
Hui, JO
Chow, DT
Markell, D
Robinson, JH
Katta, V
Nixon, L
Chang, BS
Rohde, MF
Haniu, M
机构
[1] Amgen Inc, Dept Prot Struct, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Proc Dev Boulder, Thousand Oaks, CA 91320 USA
关键词
glial cell line-derived neurotrophic factor; succinimide; isoaspartate; HPLC; mass spectrometry;
D O I
10.1006/abbi.1998.0884
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human glial cell line-derived neurotrophic factor is a single polypeptide of 134 amino acids and functions as a disulfide-linked dimer. Incubation of the protein in pH 5.0 and at 37 degrees C for 1 week showed that 5% of the material was converted to a form that eluted after the major protein peak on a cation-exchange column. The modified component gave an average molecular mass of 30367.0 u (theoretical = 30384.8 u), Within measurement error, this 17.8-u decrease in mass indicated the loss of a water molecule. This observation, together with the protein's behavior on cation-exchange chromatography and the mode of incubation used to generate the modification, was consistent with cyclic imide (succinimide) formation at an aspartyl residue. Hence, only a monomer of the dimeric protein was modified. The modified monomer was purified and subjected to peptic degradation. By a combination of N-terminal analysis and mass spectrometry, the region containing Asp(95)-Lys(96) was identified to be modified. This was further confirmed by carboxypeptidase Y digestion of the modified peptide where the modified region was found to be resistant to further enzymatic degradation. Furthermore, incubation of the modified monomer in pH 8.5 for 2 h yielded two peaks, in agreement with the succinimide model where the cyclic imide was hydrolyzed into a mixture of isoaspartate and aspartate. Tryptic mapping of the isoaspartyl-containing protein showed that Asp(95) was refractory to Edman degradation, confirming it was in the isoaspartate form. Hence, the modification observed was due to succinimide formation at Asp95. This is the first report of succinimide formation at an Asp-Lys linkage. (C) 1998 Academic Press.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 22 条
[1]   Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: Identification and effect on binding affinity [J].
Cacia, J ;
Keck, R ;
Presta, LG ;
Frenz, J .
BIOCHEMISTRY, 1996, 35 (06) :1897-1903
[2]  
CANOVADAVIS E, 1990, INT J PEPT PROT RES, V35, P17
[3]   PROPENSITY FOR SPONTANEOUS SUCCINIMIDE FORMATION FROM ASPARTYL AND ASPARAGINYL RESIDUES IN CELLULAR PROTEINS [J].
CLARKE, S .
INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1987, 30 (06) :808-821
[4]   GDNF signalling through the Ret receptor tyrosine kinase [J].
Durbec, P ;
MarcosGutierrez, CV ;
Kilkenny, C ;
Grigoriou, M ;
Wartiovaara, K ;
Suvanto, P ;
Smith, D ;
Ponder, B ;
Costantini, F ;
Saarma, M ;
Sariola, H ;
Pachnis, V .
NATURE, 1996, 381 (6585) :789-793
[5]   X-ray structure of glial cell-derived neurotrophic factor at 1.9 angstrom resolution and implications for receptor binding [J].
Eigenbrot, C ;
Gerber, N .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (06) :435-438
[6]  
GASH DM, 1996, NATURE, V380, P352
[7]   DISULFIDE STRUCTURES OF HIGHLY BRIDGED PEPTIDES - A NEW STRATEGY FOR ANALYSIS [J].
GRAY, WR .
PROTEIN SCIENCE, 1993, 2 (10) :1732-1748
[8]   Glial cell line-derived neurotrophic factor: Selective reduction of the intermolecular disulfide linkage and characterization of its disulfide structure [J].
Haniu, M ;
Hui, J ;
Young, Y ;
Le, J ;
Katta, V ;
Lee, R ;
Shimamoto, G ;
Rohde, MF .
BIOCHEMISTRY, 1996, 35 (51) :16799-16805
[9]   Role of neurotrophic factors in neuronal development [J].
Henderson, CE .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (01) :64-70
[10]   HUMAN SOMATOTROPIN - REACTION WITH HYDROGEN-PEROXIDE [J].
HOUGHTEN, RA ;
GLASER, CB ;
LI, CH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1977, 178 (02) :350-355